Mark E. Dmytruk - 20 May 2025 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Financial Officer
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Issuer symbol
DNA
Transactions as of
20 May 2025
Net transactions value
-$5,355
Form type
4
Filing time
22 May 2025, 16:05:15 UTC
Previous filing
23 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dmytruk Mark E. Chief Financial Officer C/O GINKGO BIOWORKS HOLDINGS, INC., 27 DRYDOCK AVENUE, BOSTON /s/ Karen Tepichin, Attorney-in-Fact 22 May 2025 0001873507

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Options Exercise +454 +1% 45,907 20 May 2025 Direct F1
transaction DNA Class A Common Stock Options Exercise +453 +0.99% 46,360 20 May 2025 Direct F1
transaction DNA Class A Common Stock Options Exercise +572 +1.2% 46,932 20 May 2025 Direct F1
transaction DNA Class A Common Stock Sale $5,355 -706 -1.5% $7.58 46,226 21 May 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Options Exercise -454 -11% 3,614 20 May 2025 Class A Common Stock 454 Direct F1
transaction DNA Restricted Stock Units Options Exercise -453 -4.3% 9,970 20 May 2025 Class A Common Stock 453 Direct F1, F3
transaction DNA Restricted Stock Units Options Exercise -572 -2.9% 19,488 20 May 2025 Class A Common Stock 572 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F3 The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F4 The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.

Remarks:

Chief Financial Officer